Clinical trial
BOND HeartGPS: A Longitudinal Randomized Controlled Trial Examining the Maternal and Infant Effects of a Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
NCT07582861 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BOND HeartGPS: A Longitudinal Randomized Controlled Trial Examining the Maternal and Infant Effects of a Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
- Lead sponsor
- Carelon Research
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 22, 2026
- Completion date
- August 31, 2030
- Enrollment
- 210 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease (chd)